Biocryst Pharmaceuticals (BCRX) Cash & Equivalents (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Cash & Equivalents of $154.97 million in Q2 2026, up 76.0% from $88.03 million a year earlier but down 9.7% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals reported Cash & Equivalents of $89.74 million, down 14.3% from FY2024.
- Annual Cash & Equivalents has declined for four straight years, with a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $104.71 million in FY2024 (-5.4%), $110.64 million in FY2023 (-63.7%), $304.77 million in FY2022 (-39.6%) and $504.39 million in FY2021 (+85.4%).
- Quarterly Cash & Equivalents has ranged from $78.41 million in Q2 2024 to $504.39 million in Q4 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 13.4%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 106.9% in Q3 2021, against a decline of 63.7% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $171.59 million (Q1 2026), $89.74 million (Q4 2025) and $84.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn | 154.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.97 Mn |
| Mar 31, 2026 | 171.59 Mn |
| Dec 31, 2025 | 89.74 Mn |
| Sep 30, 2025 | 84.08 Mn |
| Jun 30, 2025 | 88.03 Mn |
| Mar 31, 2025 | 105.19 Mn |
| Dec 31, 2024 | 104.71 Mn |
| Sep 30, 2024 | 96.84 Mn |
| Jun 30, 2024 | 78.41 Mn |
| Mar 31, 2024 | 84.33 Mn |
| Dec 31, 2023 | 110.64 Mn |
| Sep 30, 2023 | 150.91 Mn |
| Jun 30, 2023 | 146.22 Mn |
| Mar 31, 2023 | 155.14 Mn |
| Dec 31, 2022 | 304.77 Mn |
| Sep 30, 2022 | 246.90 Mn |
| Jun 30, 2022 | 272.57 Mn |
| Mar 31, 2022 | 395.50 Mn |
| Dec 31, 2021 | 504.39 Mn |
| Sep 30, 2021 | 199.60 Mn |
API Access
Biocryst Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();